Twist Bioscience Corp
NASDAQ:TWST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Twist Bioscience Corp
NASDAQ:TWST
|
US |
|
Elicio Therapeutics Inc
NASDAQ:ELTX
|
US |
|
F
|
Fraser & Neave Holdings Bhd
KLSE:F&N
|
MY |
|
Fission Uranium Corp
TSX:FCU
|
CA |
|
Agnico Eagle Mines Ltd
TSX:AEM
|
CA |
|
N
|
Northgold AB
STO:NG
|
SE |
|
Pilbara Minerals Ltd
ASX:PLS
|
AU |
|
Sonos Inc
NASDAQ:SONO
|
US |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
SeQuent Scientific Ltd
NSE:SEQUENT
|
IN |
Wall Street
Price Targets
TWST Price Targets Summary
Twist Bioscience Corp
According to Wall Street analysts, the average 1-year price target for
TWST
is 51.61 USD
with a low forecast of 36.36 USD and a high forecast of 60.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TWST's stock price target?
Price Target
51.61
USD
According to Wall Street analysts, the average 1-year price target for
TWST
is 51.61 USD
with a low forecast of 36.36 USD and a high forecast of 60.9 USD.
What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Twist Bioscience Corp's revenue is
56%.
The projected
CAGR
for the next 3 years is
16%.